Ellen Tedaldi, MD, Professor of Internal Medicine, Director of HIV Program, Temple University School of Medicine, discusses HIV/AIDS treatments.

References and Resources
Jin H, Wright M, Pastor R, et al. Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs. 2008. Bioorg Med Chem Lett.

Evering TH, Markowitz M. Raltegravir (MK-0518): An integrase inhibitor for the treatment of HIV-1. Drugs Today (Barc). 2007 Dec;43(12):865-77.

Jones R, Nelson M. The role of receptors in the HIV-1 entry process. Eur J Med Res. 2007 Oct 15;12(9):391-6. Review.

Related Videos on The Doctor’s Channel:
Screening for HIV and Treatment of Acquired Immunodeficiency
HIV Screening
Rapid HIV Testing
HIV/AIDS Medication Non-Compliance and the Spread of HIV

Sponsored by The Doctor’s Channel